Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab ; volume:50 ; number:03 ; year:2019 ; pages:193-196
Neuropediatrics ; 50, Heft 03 (2019), 193-196
- Contributor
-
Breu, Markus
Glatter, Sarah
Höftberger, Romana
Freilinger, Michael
Kircher, Karl
Kasprian, Gregor Johannes
Seidl, Rainer
Kornek, Barbara
- DOI
-
10.1055/s-0039-1684004
- URN
-
urn:nbn:de:101:1-2019070810013738169518
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Breu, Markus
- Glatter, Sarah
- Höftberger, Romana
- Freilinger, Michael
- Kircher, Karl
- Kasprian, Gregor Johannes
- Seidl, Rainer
- Kornek, Barbara
Other Objects (12)
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
The history of neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica
The Gut Microbiome in Neuromyelitis Optica
Neuromyelitis optica pathogenesis and aquaporin 4
Kognition bei Neuromyelitis optica-Spektrum-Erkrankung
Extensive Cerebral Cortical Involvement in Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder
Dysregulated B cell differentiation towards antibody-secreting cells in neuromyelitis optica spectrum disorder
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
The history of neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica
The Gut Microbiome in Neuromyelitis Optica
Neuromyelitis optica pathogenesis and aquaporin 4
Kognition bei Neuromyelitis optica-Spektrum-Erkrankung
Extensive Cerebral Cortical Involvement in Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder
Dysregulated B cell differentiation towards antibody-secreting cells in neuromyelitis optica spectrum disorder
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
The history of neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica
The Gut Microbiome in Neuromyelitis Optica
Neuromyelitis optica pathogenesis and aquaporin 4
Kognition bei Neuromyelitis optica-Spektrum-Erkrankung
Extensive Cerebral Cortical Involvement in Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder